Bacil Pharma (BSE: BACPHAR) closed at ₹16.08 on 20 Nov 2026, with a market value of ₹23 crore.
Bacil Pharma (BSE: BACPHAR) closed at ₹16.08 on 20 Nov 2026, down 55.4% over the past year. Its market capitalisation is ₹23 crore and it trades at 14.8 times earnings.
Bacil Pharma Limited is a Mumbai-registered listed company incorporated in 1987. Although its stated business is pharmaceutical healthcare, it recorded no core operating revenue in FY26 and is currently an investment/other-income-led, non-operating company evaluating future business opportunities.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.